In patients with NET, especially if of pancreatic origin and associated with other factors such as other MEN1-related manifestations, age, multifocality, and associated endocrine syndromes, genetic screening is useful to achieve an early diagnosis of MEN, set up related treatment and follow-up, and start the genetic screening in first-degree relatives. This evidence concerns the gene MEN1 and multiple endocrine neoplasia.